Created in 2004 (United States), IMMULAST own 218 sister brands and 4958 competing brands. IMMULAST is owned by Zoetis, listed on the stock exchange of New York The sector of IMMULAST is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Zoetis
(IMMULAST)
over 5 years*
USD 244.80